Assignee
NALPROPION PHARMACEUTICALS INC
US·4 granted patents·4 pending applications·24 citations·filing 2014–2019
Top patents by PatentIndex Score
8 records- 0191US10231964B2Compositions and methods for weight loss in at risk patient populationsNALPROPION PHARMACEUTICALS INC·Filed 2017·Granted Mar 19, 2019·8 cites·20 claims
- 0289US10307376B2Methods for administering weight loss medicationsNALPROPION PHARMACEUTICALS INC·Filed 2018·Granted Jun 4, 2019·5 cites·20 claims
- 0387US10403170B2Methods of treating overweight and obesityNALPROPION PHARMACEUTICALS INC·Filed 2017·Granted Sep 3, 2019·6 cites·20 claims
- 0485US10231962B2Compositions and methods for reducing major adverse cardiovascular eventsNALPROPION PHARMACEUTICALS INC·Filed 2014·Granted Mar 19, 2019·5 cites·14 claims
- 0572US2019183883A1Sustained Release Formulation Of NaltrexoneNALPROPION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0671US2019358222A1Increasing Drug Bioavailability In Naltrexone TherapyNALPROPION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0768US2019282503A1Methods For Administering Weight Loss MedicationsNALPROPION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0863US2019231852A1Compositions And Methods For Increasing Insulin SensitivityNALPROPION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →